BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gershwin ME. The mosaic of autoimmunity. Autoimmun Rev 2008;7:161-3. [PMID: 18190871 DOI: 10.1016/j.autrev.2007.11.021] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Conrad K, Shoenfeld Y, Fritzler MJ. Precision health: A pragmatic approach to understanding and addressing key factors in autoimmune diseases. Autoimmun Rev 2020;19:102508. [PMID: 32173518 DOI: 10.1016/j.autrev.2020.102508] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
2 Arneth BM. Activation of CD4 and CD8 T cell receptors and regulatory T cells in response to human proteins. PeerJ 2018;6:e4462. [PMID: 29568705 DOI: 10.7717/peerj.4462] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
3 Arneth B. Autoimmune disease development based on possible mislocalization of intracellular and extracellular proteins. Immunobiology 2017;222:842-6. [PMID: 28318800 DOI: 10.1016/j.imbio.2017.02.007] [Reference Citation Analysis]
4 Joo J, Cha GS, Chung J, Lee J, Kim S, Choi J. Peptide 19 of Porphyromonas gingivalis Heat Shock Protein Is a Potent Inducer of Low-Density Lipoprotein Oxidation. Journal of Periodontology 2017;88:e58-64. [DOI: 10.1902/jop.2016.160402] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
5 Yu S, Liao E, Tsai J. Der p 2 can induce bystander activation of B cells derived from patients with systemic lupus erythematosus. Immunobiology 2014;219:958-63. [DOI: 10.1016/j.imbio.2014.07.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
6 Vojdani A. A Potential Link between Environmental Triggers and Autoimmunity. Autoimmune Dis. 2014;2014:437231. [PMID: 24688790 DOI: 10.1155/2014/437231] [Cited by in Crossref: 31] [Cited by in F6Publishing: 59] [Article Influence: 3.9] [Reference Citation Analysis]
7 Moriyama M, Tanaka A, Maehara T, Furukawa S, Nakashima H, Nakamura S. T helper subsets in Sjögren's syndrome and IgG4-related dacryoadenitis and sialoadenitis: a critical review. J Autoimmun 2014;51:81-8. [PMID: 23920005 DOI: 10.1016/j.jaut.2013.07.007] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 5.3] [Reference Citation Analysis]
8 Nussinovitch U, Shoenfeld Y. The diagnostic and clinical significance of anti-muscarinic receptor autoantibodies. Clin Rev Allergy Immunol 2012;42:298-308. [PMID: 21207192 DOI: 10.1007/s12016-010-8235-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
9 Efe C. Drug induced autoimmune hepatitis and TNF-α blocking agents: is there a real relationship? Autoimmun Rev. 2013;12:337-339. [PMID: 22841985 DOI: 10.1016/j.autrev.2012.03.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
10 Sardi F, Fassina L, Venturini L, Inguscio M, Guerriero F, Rolfo E, Ricevuti G. Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly. Autoimmunity Reviews 2011;11:149-53. [DOI: 10.1016/j.autrev.2011.09.005] [Cited by in Crossref: 104] [Cited by in F6Publishing: 99] [Article Influence: 9.5] [Reference Citation Analysis]
11 Youinou P, Pers JO. Disturbance of cytokine networks in Sjögren’s syndrome. Arthritis Res Ther. 2011;13:227. [PMID: 21745420 DOI: 10.1186/ar3348] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 7.0] [Reference Citation Analysis]
12 Kivity S, Agmon-Levin N, Zisappl M, Shapira Y, Nagy EV, Dankó K, Szekanecz Z, Langevitz P, Shoenfeld Y. Vitamin D and autoimmune thyroid diseases. Cell Mol Immunol 2011;8:243-7. [PMID: 21278761 DOI: 10.1038/cmi.2010.73] [Cited by in Crossref: 117] [Cited by in F6Publishing: 117] [Article Influence: 10.6] [Reference Citation Analysis]
13 Nussinovitch U, Shoenfeld Y. The Clinical and Diagnostic Significance of Anti-myosin Autoantibodies in Cardiac Disease. Clinic Rev Allerg Immunol 2013;44:98-108. [DOI: 10.1007/s12016-010-8229-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
14 Nussinovitch U, Shoenfeld Y. The Clinical Significance of Anti-Beta-1 Adrenergic Receptor Autoantibodies in Cardiac Disease. Clinic Rev Allerg Immunol 2013;44:75-83. [DOI: 10.1007/s12016-010-8228-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
15 Routsias JG, Tzioufas AG. B-cell epitopes of the intracellular autoantigens Ro/SSA and La/SSB: Tools to study the regulation of the autoimmune response. Journal of Autoimmunity 2010;35:256-64. [DOI: 10.1016/j.jaut.2010.06.016] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
16 Manoussakis MN, Kapsogeorgou EK. The role of intrinsic epithelial activation in the pathogenesis of Sjögren’s syndrome. Journal of Autoimmunity 2010;35:219-24. [DOI: 10.1016/j.jaut.2010.06.011] [Cited by in Crossref: 104] [Cited by in F6Publishing: 100] [Article Influence: 8.7] [Reference Citation Analysis]
17 Youinou P. Haralampos M. Moutsopoulos: A lifetime in autoimmunity. Journal of Autoimmunity 2010;35:171-5. [DOI: 10.1016/j.jaut.2010.06.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
18 Kontaki E, Boumpas DT. Innate immunity in systemic lupus erythematosus: Sensing endogenous nucleic acids. Journal of Autoimmunity 2010;35:206-11. [DOI: 10.1016/j.jaut.2010.06.009] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
19 Kapsogeorgou EK, Manoussakis MN. Salivary gland epithelial cells (SGEC): Carriers of exquisite B7-2 (CD86) costimulatory molecules. Journal of Autoimmunity 2010;35:188-91. [DOI: 10.1016/j.jaut.2010.06.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
20 Wiik AS, Høier-madsen M, Forslid J, Charles P, Meyrowitsch J. Antinuclear antibodies: A contemporary nomenclature using HEp-2 cells. Journal of Autoimmunity 2010;35:276-90. [DOI: 10.1016/j.jaut.2010.06.019] [Cited by in Crossref: 113] [Cited by in F6Publishing: 83] [Article Influence: 9.4] [Reference Citation Analysis]
21 Mavragani CP, Crow MK. Activation of the type I interferon pathway in primary Sjogren’s syndrome. Journal of Autoimmunity 2010;35:225-31. [DOI: 10.1016/j.jaut.2010.06.012] [Cited by in Crossref: 114] [Cited by in F6Publishing: 95] [Article Influence: 9.5] [Reference Citation Analysis]
22 Manoussakis MN, Spachidou MP, Maratheftis CI. Salivary epithelial cells from Sjogren's syndrome patients are highly sensitive to anoikis induced by TLR-3 ligation. J Autoimmun 2010;35:212-8. [PMID: 20685081 DOI: 10.1016/j.jaut.2010.06.010] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
23 Passam FH, Qi JC, Tanaka K, Matthaei KI, Krilis SA. In vivo modulation of angiogenesis by beta 2 glycoprotein I. J Autoimmun 2010;35:232-40. [PMID: 20655705 DOI: 10.1016/j.jaut.2010.06.013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
24 Miyagawa F, Gutermuth J, Zhang H, Katz SI. The use of mouse models to better understand mechanisms of autoimmunity and tolerance. J Autoimmun. 2010;35:192-198. [PMID: 20655706 DOI: 10.1016/j.jaut.2010.06.007] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
25 Bernuzzi F, Fenoglio D, Battaglia F, Fravega M, Gershwin ME, Indiveri F, Ansari AA, Podda M, Invernizzi P, Filaci G. Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis. J Autoimmun. 2010;35:176-180. [PMID: 20638239 DOI: 10.1016/j.jaut.2010.06.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
26 Vlachoyiannopoulos PG, Routsias JG. A novel mechanism of thrombosis in antiphospholipid antibody syndrome. J Autoimmun 2010;35:248-55. [PMID: 20638238 DOI: 10.1016/j.jaut.2010.06.015] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
27 Leung PS, Shu SA, Kenny TP, Wu PY, Tao MH. Development and validation of gene therapies in autoimmune diseases: Epidemiology to animal models. Autoimmun Rev 2010;9:A400-5. [PMID: 20035901 DOI: 10.1016/j.autrev.2009.12.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
28 Selmi C, Meda F, Kasangian A, Invernizzi P, Tian Z, Lian Z, Podda M, Gershwin ME. Experimental evidence on the immunopathogenesis of primary biliary cirrhosis. Cell Mol Immunol 2010;7:1-10. [PMID: 20029462 DOI: 10.1038/cmi.2009.104] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
29 Shoenfeld Y, Gershwin ME. Preface: The Autoimmunologist and the Congresses of Autoimmunity. Annals of the New York Academy of Sciences 2009;1173:1-3. [DOI: 10.1111/j.1749-6632.2009.04949.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
30 Arneth BM. In vitro model for the activation of CD4 and CD8 T cell receptors. Hum Immunol 2009;70:670-7. [PMID: 19500630 DOI: 10.1016/j.humimm.2009.05.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Kikuchi K, Hsu W, Hosoya N, Moritoki Y, Kajiyama Y, Kawai T, Takai A, Hayami E, Selmi C, Gershwin ME, Miyakawa H. Ursodeoxycholic acid reduces CpG-induced IgM production in patients with primary biliary cirrhosis. Hepatology Research 2009;39:448-54. [DOI: 10.1111/j.1872-034x.2008.00474.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
32 Dhirapong A, Lleo A, Leung P, Gershwin ME, Liu FT. The immunological potential of galectin-1 and -3. Autoimmun Rev. 2009;8:360-363. [PMID: 19064001 DOI: 10.1016/j.autrev.2008.11.009] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 5.1] [Reference Citation Analysis]
33 Lorusso L, Mikhaylova SV, Capelli E, Ferrari D, Ngonga GK, Ricevuti G. Immunological aspects of chronic fatigue syndrome. Autoimmun Rev 2009;8:287-91. [PMID: 18801465 DOI: 10.1016/j.autrev.2008.08.003] [Cited by in Crossref: 155] [Cited by in F6Publishing: 154] [Article Influence: 11.1] [Reference Citation Analysis]
34 Doria A, Sarzi-Puttini P, Shoenfeld Y. Infections, rheumatism and autoimmunity: the conflicting relationship between humans and their environment. Autoimmun Rev 2008;8:1-4. [PMID: 18707029 DOI: 10.1016/j.autrev.2008.07.014] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 3.9] [Reference Citation Analysis]